试用视觉搜索
使用图片进行搜索,而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索,请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等(默认)
关闭
筛选器
1200×800
bloomberg.com
Biogen Drops After Alzheimer's Drug Trial Change Raises Concerns ...
2000×1262
thehealthcaretechnologyreport.com
Biogen Seeks Approval For New Alzheimer’s Drug | The Healthcare ...
900×600
pharmaphorum.com
Biogen pulls the plug on late-stage Parkinson’s trial | pharmaphorum
1024×576
statnews.com
Biogen believes failed Alzheimer’s trials may still offer clues to way ...
1600×900
bdc-tv.com
How drug company Biogen became COVID-19 ‘super spreader’ – BDC TV
1200×630
biogen.com
Contact Us | Biogen
1440×864
Valley News
Biogen reanalyzes studies, presses ahead on Alzheimer’s drug | Valle…
1200×676
bizjournals.com
Biogen shares jump despite mixed news on rare disease drugs - Boston ...
847×565
geneonline.com
Biogen Concludes $900 Million Settlement Before Posting Positiv…
1200×800
worldecomag.com
Big Biogen boost on Alzheimer's news could win back biotech inve…
931×506
foxbusiness.com > Lucas Manfredi
Biogen to pay $900M to settle allegations of improper physician ...
1024×575
3blmedia.com
Biogen Releases 2021 Year In Review
760×428
today.com
Biogen will seek federal approval for new Alzheimer’s drug
2000×1333
bloomberg.com
Biogen Makes Biggest M&A Bet to Date on Rare Diseases with Reat…
1024×576
axios.com
Biogen says FDA didn't push for trial before Alzheimer's approval
1400×933
schaeffersresearch.com
Research Paper Reports Death in Biogen's Experimental Drug
1350×900
Forbes
Biogen: Not Worth A Buy Unless It Buys
1200×800
bloomberg.com
Biogen (BIIB) 2022 Hangs on Alzheimer's Therapy Aduhelm - Bloo…
2048×1365
nytimes.com
Biogen’s Alzheimer’s drug is unlikely to win E.U. approval. - The New ...
1280×853
bostonglobe.com
Biogen falls back to earth as Samsung denies merger reports - The ...
2238×1492
reuters.com
U.S. Supreme Court turns away Biogen bid to reinstate MS drug p…
4690×3019
reuters.com
Biogen's 2022 forecast well below Street view on Alzheimer's drug ...
750×450
ddw-online.com
Biogen acquires Reata and cuts 1,000 jobs - Drug Discovery World (DDW)
1320×742
marketwatch.com
Biogen tops earnings expectations, but still has some longer-term ...
860×573
wsj.com
Biogen Agrees to Pay $900 Million Over Alleged Improper Physician ...
750×563
europeanpharmaceuticalreview.com
Biogen to acquire rare disease drugmaker for $7.3b
1200×630
biogen.com
Stories | Biogen
860×574
mmm-online.com
Biogen clinches first-mover status on disease-modifying Alzheimer’s ...
1200×800
reuters.com
Biogen trial of ALS drug fails main goal, but company says data are ...
756×453
cafepharma.com
February 3 2022 - After disastrous launch start, Biogen still expects ...
1200×630
The Epoch Times
Three Biogen Workers Test Positive for New Coronavirus After Boston Meeting
860×573
wsj.com
Biogen Details Case for Controversial Alzheimer’s Drug - …
1920×1080
axios.com
Biogen shakeup could shift Alzheimer's research
880×587
fiercebiotech.com
Biogen takes nuclear option, terminating Karyopharm ALS pact
1280×853
bostonglobe.com
‘It’s night and day’: Biogen’s new Alzheimer’s drug may spur more ...
某些结果已被隐藏,因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
Invisible focusable element for fixing accessibility issue
反馈